News
Poseida Therapeutics to Present at Upcoming Virtual Investor Conferences
SAN DIEGO, April 8, 2021 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, today announced that the Company will participate in the following upcoming virtual investor conferences:
Raymond James Cell Therapy for Oncology Symposium
Start-up to Scale-up: A Discussion on Manufacturing of Off The Shelf Cell Based Therapy
Panel discussion with Poseida CEO Eric Ostertag, MD, PhD
Thursday, April 22, 2021
9:00am ET
7th Annual Truist Securities 2021 Life Sciences Summit
Fireside Chat with Poseida CEO Eric Ostertag, MD, PhD
Wednesday, May 5, 2021
3:30pm ET